Latest News

  • Invitae Announces Final Medicare Pricing For Hereditary Breast Cancer-Related Disorders

    Diagnostics World Brief | Invitae announced that the Centers for Medicare and Medicaid Services announced final pricing for genetic testing for hereditary breast cancer-related disorders.

    Oct 3, 2016
  • The Fifty Days of the DRAGEN

    Diagnostics World | In the world of next-generation sequencing (NGS) research and diagnostics, 2016 is shaping up to be a big year for the Broad Institute's Genome Analysis Toolkit (GATK). Several announcements and releases this year have helped make the platform ever more ubiquitous as even Broad competitors have partnered up with the nonprofit for GATK compatibility.

    Sep 30, 2016
  • Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits

    Diagnostics World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.

    Sep 29, 2016
  • News and Notes in Diagnostics September 2016

    Diagnostics World News Briefs | News from MDxHealth, Xcell Biosciences, Canon, and more.

    Sep 29, 2016
  • Why I Won’t Get the Genetic Test for Breast Cancer

    WIRED | BRCA is a powerful tool to estimate cancer risk, but it's not a crystal ball. And I don't want the results of one imperfect test to propel me into surgery.

    Sep 27, 2016
  • Color Genomics Raises $45 Million To Expand Genetic Testing

    Bloomberg | Color Genomics Inc., the three-year-old startup aiming to democratize genetic testing, sealed $45 million in funding as it seeks to make its tests for cancer more affordable and accessible, the company announced Tuesday.

    Sep 27, 2016
  • Time Stretch Microscopy And Machine Learning: Powerful Tools For Cancer Diagnostics

    Diagnostics World | Researchers at Stanford University and UCLA are bringing the latest in machine learning and digital image processing to bear on cancer diagnostics, expanding the toolkit for physicians.

    Sep 27, 2016
  • ResApp Brings Remote Diagnosis Of Respiratory Disease Via Mobile App

    Diagnostics World | ResApp Health Limited believes its mobile health app can replace stethoscopes as the go-to technology for diagnosing a variety of respiratory conditions. The Perth, Australia-based company is adequately capitalized, operationally prepared, and armed with competitive data needed to launch ResApp in the United States.

    Sep 23, 2016
  • How Machine Learning Big Data And AI Are Changing Healthcare Forever

    Forbes | Machine learning is improving diagnostics, predicting outcomes, and just beginning to scratch the surface of personalized care.

    Sep 23, 2016
  • Consortium Last Month Seeks Context For Undiagnosed Patients

    Diagnostics World | The UnDx Consortium met in San Diego last month as a proof of concept attempt to add context to the sequencing and medical records of undiagnosed patients. Five companies working on metabolomics, epigenetics, microbiome analysis, stem cells and regenerative medicine, and chromosomal rearrangements brought their technologies to bear on six patients seeking answers.

     id="d_dlg" classid="clsid:3050f819-98b5-11cf-bb82-00aa00bdce0b" width="0px" height="0px">mmmmmmmmlli

    Sep 20, 2016
  • Research Holds Promise Of Leading To Ways To Stop Breast Cancer From Spreading

    Forbes | Research that uncovered a mechanism that allows breast cancer cells to enter the bloodstream opens the door to early identification of women who are at increased risk of metastasizing breast cancer and provides a target for further research aimed at keeping breast cancer from spreading throughout the body.

    Sep 16, 2016
  • RNA Biosignatures: Overcoming Hurdles In Diagnosing Childhood Bacterial Infections

    Diagnostics World News | New studies discuss techniques that could help distinguish bacterial and viral infections.

    Sep 14, 2016
  • Study Compares Survival Outcomes Of Lung Cancer Staging Strategies

    News-Medical | In a study appearing in the September 13 issue of JAMA, Jouke T. Annema, M.D., Ph.D., of the Academic Medical Center, Amsterdam, and colleagues examined five-year survival after endosonography vs mediastinoscopy for mediastinal nodal staging of lung cancer.

    Sep 13, 2016
  • As Zika Spreads In Asia Study Shows Virus May Also Infect Adult Brain Cells

    Forbes | A new study shows that the Zika virus can infect regions of brain cells associated with learning and memory in adult mice -- suggesting potential implications for adult brains in humans.

    Sep 12, 2016
  • A Map To Help Cancer Doctors Find Their Way

    NPR | A computer program can map cancer progression in much the same way historical explorers drew maps of the Earth without satellite imaging. Small bits of data can be pieced together to form a picture.

    Sep 12, 2016
  • Penn. Researchers Prefer Liquid Biopsy To Tissue Biopsy In Lung Cancer

    News-Medical | For patients with advanced lung cancer, a non-invasive liquid biopsy may be a more effective and suitable alternative to the gold standard tissue biopsy to detect clinically relevant mutations and help guide their course of treatment, suggests a new study published this week in the journal Clinical Cancer Research from researchers at the Abramson Cancer Center at the University of Pennsylvania.

    Sep 9, 2016
  • Diagnostics In DC: FDA Guidances, NGS Assays And Clinical Workflows At The Next Generation Diagnostics Summit

    Diagnostics World | Diagnostics is exploding thanks to next generation technologies. Advances in NGS assays, point-of-care diagnostics, companion diagnostics, DNA forensics, struggles with interpretation and incidental findings, and the regulatory structure surrounding all of it were the topics of three days of conversations in late August at the Next Generation Diagnostics Summit in Washington, D.C.

     id="d_dlg" classid="clsid:3050f819-98b5-11cf-bb82-00aa00bdce0b" width="0px" height="0px">mmmmmmmmlli

    Sep 8, 2016
  • FDA Warns Against Widely Used Ovarian Cancer Screening Test

    STAT | The FDA warned women and their doctors that current screening tests for ovarian cancer are unreliable, and could lead to false diagnoses.

    Sep 8, 2016
  • Genomic Medicine And Managing The Shift To The Clinic

    Diagnostics World | At a genomic medicine gathering in Huntsville, Alabama, last month, researchers and physicians called a new paradigm of genomic medicine and sequencing shifts from research use into the clinic. 

    Sep 6, 2016